SCHEMBL15825702

SCHEMBL15825702

Cc1nc(C(F)F)c(C(=O)Nc2cccc3c2CCC(C)(C)C3)s1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FABP4 P15090 3/20 0.37
▸ FABP5 Q01469 3/20 0.37
▸ L3MBTL1 Q9Y468 3/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ RECQL P46063 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ KMT2A Q03164 4/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ BACE1 P56817 1/20 0.33
▸ KIF11 P52732 1/20 0.33
▸ MAPK8 P45983 1/20 0.33
▸ MAPK10 P53779 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ CNR1 P21554 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15825855 0.88 FABP4 (0.32) FABP4FABP5
SCHEMBL28901441 0.80 RAB9A (0.36) L3MBTL1RAB9ASMN1; SMN2RECQLNPC1
SCHEMBL15825905 0.78 L3MBTL1 (0.38) FABP4FABP5L3MBTL1SMN1; SMN2KDM4E
SCHEMBL16670252 0.77 LMNA (0.38) L3MBTL1SMN1; SMN2KDM4EALDH1A1TSHR
SCHEMBL12903702 0.75 HTT (0.51) L3MBTL1RAB9ASMN1; SMN2RECQLNPC1
SCHEMBL2911307 0.74 RAB9A (0.46) L3MBTL1RAB9ASMN1; SMN2RECQLNPC1
SCHEMBL13478940 0.72 ALDH1A1 (0.43) L3MBTL1RAB9ASMN1; SMN2RECQLNPC1
SCHEMBL28901449 0.72 BACE1 (0.34) RAB9ASMN1; SMN2RECQLNPC1TP53
SCHEMBL13064249 0.71 TSHR (0.50) RAB9ARECQLNPC1KDM4EALDH1A1
SCHEMBL15826550 0.71 L3MBTL1 (0.42) FABP4FABP5L3MBTL1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9630943-B2 Tetrahydronaphthyl(thio) carboxamides BAYER CROPSCIENCE AG (DE) 2017-04-25 — — US disclosed
US-20150329517-A1 TETRAHYDRONAPHTHYL(THIO) CARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2015-11-19 — — US disclosed
EP-2935223-A1 TETRAHYDRONAPHTHYL(THIO) CARBOXAMIDES Bayer CropScience AG (DE) 2015-10-28 — — EP disclosed
WO-2014095678-A1 TETRAHYDRONAPHTHYL(THIO) CARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2014-06-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329517-A1 TETRAHYDRONAPHTHYL(THIO) CARBOXAMIDES HDHD5, TPMT, TIAL1 FABP4 3684/4885FABP5 2517/4885L3MBTL1 419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback